Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Proto-oncogene protein c-Met receptor (c-Met) is a receptor tyrosine kinase with critical roles in normal physiology and cancer biology. It is activated by hepatocyte growth factor (HGF) and regulates cell proliferation, motility, morphogenesis, and survival. Dysregulation of c-Met, through overexpression or activating mutations, is implicated in various solid tumors, making it an important therapeutic target.
Tyrosine kinase inhibition
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Proto-oncogene protein c-Met receptor (c-Met).